Finerenone Added to Treatment Guidelines for Type 2 Diabetes and Chronic Kidney Disease.

Humans Diabetes Mellitus, Type 2 / drug therapy Mineralocorticoid Receptor Antagonists / adverse effects Double-Blind Method Renal Insufficiency, Chronic / drug therapy

Journal

The American journal of nursing
ISSN: 1538-7488
Titre abrégé: Am J Nurs
Pays: United States
ID NLM: 0372646

Informations de publication

Date de publication:
01 05 2023
Historique:
medline: 21 4 2023
pubmed: 20 4 2023
entrez: 20 04 2023
Statut: ppublish

Résumé

The use of finerenone is now included in the 2022 revision to standard treatment guidelines for patients with type 2 diabetes and chronic kidney disease.Finerenone is a costly addition to standard treatment. Patients may need to receive prescription preauthorization from their insurer.

Identifiants

DOI: 10.1097/01.NAJ.0000933932.29825.ee PMID: 37077016
pubmed: 37077016
doi: 10.1097/01.NAJ.0000933932.29825.ee
pii: 00000446-202305000-00017
doi:

Substances chimiques

finerenone 0
Mineralocorticoid Receptor Antagonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Auteurs

Diane S Aschenbrenner (DS)

Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She coordinates Drug Watch : diane.aschenbrenner@gmail.com .

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Finerenone Added to Treatment Guidelines for...
questionsmedicales.fr › Maladies endocriniennes › Diabète › Diabète de type 2 › Finerenone Added to Treatment Guidelines for...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Diurétiques › Diurétiques d'épargne potassique › Antagonistes des récepteurs des minéralocorticoïdes › Finerenone Added to Treatment Guidelines for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Méthode en double aveugle › Finerenone Added to Treatment Guidelines for...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Insuffisance rénale chronique › Finerenone Added to Treatment Guidelines for...